Prescription drug · UNAPPROVED DRUG OTHER
Physician EZ Use Joint Tunnel and Trigger Kit II NDC 76420-624
lidocaine hydrochloride, triamcinolone acetonide, povidone-iodine · Kit · Asclemed USA, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 76420-624-01 | 76420062401 | 1 KIT in 1 CARTON (76420-624-01) * 25 VIAL in 1 CARTON (70121-1049-5) / 1 mL in 1 VIAL * 100 PACKET in 1 BOX (53329-941-30) / 1 mL in 1 PACKET * 2 mL in 1 AMPULE (0409-4713-42)Marketed from Dec 23, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Physician EZ Use Joint Tunnel and Trigger Kit II
- Generic name (nonproprietary)
- lidocaine hydrochloride, triamcinolone acetonide, povidone-iodine
- Dosage form
- Kit
- Labeler
- Asclemed USA, Inc.
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 76420-624_47db08a3-0644-0b9c-e063-6394a90aa03aSPL ID 47db08a3-0644-0b9c-e063-6394a90aa03aSPL set ID 0d2d52ef-ff21-4b28-b8ae-6a46570f7a74RxCUI 797730, 1737568, 1792144
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N476420062401followed by a unit qualifier and the quantityPackage 76420-0624-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary …
Excerpt only. Read the full label for complete information.